BIJUVA
Moderate-to-severe vasomotor symptoms due to menopause
ApprovedSold (to Mayne Pharma)
Key Facts
Indication
Moderate-to-severe vasomotor symptoms due to menopause
Phase
Approved
Status
Sold (to Mayne Pharma)
Company
About TherapeuticsMD
TherapeuticsMD, Inc. is a public company that historically specialized in creating advanced hormone therapy solutions for women's health, particularly in contraception and menopause management. Its major achievement was securing FDA approval for two novel products: a long-acting reversible contraceptive and a bio-identical hormone therapy. After facing commercialization challenges and financial pressures, the company divested its prescription business to Mayne Pharma in 2022 and currently focuses on its over-the-counter prenatal vitamin, vitaMedMD, while exploring strategic alternatives for its remaining assets.
View full company profile